SavedAdd your journal

Journals / Cyprus Journal of Medical Sciences / 2021 / Cilt: 6 - Sayı: 1

Unicentric Retroperitoneal Mass: Castleman's Disease

Feyyaz GÜNGÖR
Erdinç KAMER
Ahmet ER
Ahmet ATASEVER
Mustafa PESKERSOY
Pages
103–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we present a male patient aged 36 years presenting with dyspepsia and incidentally diagnosed with unicentric CD by reviewing the data from literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Castleman's disease (CD) is a rare cause of lymphadenopathy.
📊
Key Findings & Data:Its pathophysiology is unclear.
💡
Conclusion & Impact:In this study, we present a male patient aged 36 years presenting with dyspepsia and incidentally diagnosed with unicentric CD by reviewing the data from literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Castleman's disease (CD) is a rare cause of lymphadenopathy. Its pathophysiology is unclear. It is usually asymptomatic and is incidentally detected. The treatment of unicentric CD is complete removal of the mass, and its recurrence is very rare. In this study, we present a male patient aged 36 years presenting with dyspepsia and incidentally diagnosed with unicentric CD by reviewing the data from literature.

🔖

Cite This Article

GÜNGÖR, F., KAMER, E., ER, A., ATASEVER, A., PESKERSOY, M. (2021). Unicentric Retroperitoneal Mass: Castleman's Disease. Cyprus Journal of Medical Sciences, Cilt: 6 - Sayı: 1, 103–104. https://ajindex.com/articles/418167

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control 2014; 21(4): 266-78. [Crossref] 2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma- cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29(3): 670-83. [Crossref] 3. Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol 2004; 43(8): 698-704. [Crossref] 4. Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman’s disease: a systematic review of 404 published cases. Ann Surg 2012; 255(4): 677-84. [Crossref] 5. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9(4): 822-30. [Crossref] 6. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95(4): 1406-12. [Crossref] 7. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92(3): 670-6. [Crossref]